Tag: Sonova



Nuheara Appoints John Luna as US CEO; Explores US Listing

Nuheara’s hearing device market presence in the US has been developing since the Company’s inception. In building brand awareness with Direct To Consumer (DTC) and traditional retail sales partners, the US currently holds the majority of Nuheara’s global sales and growth, according to the company.

Sonova to Acquire 3.7% Ownership Stake in Sensorion

Sensorion, a clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat, and prevent within the field of hearing loss disorders, announced that Sonova Holding AG will acquire a 3.7% ownership stake in Sensorion by way of subscription to a reserved share capital increase for total gross proceeds of €5 million (USD $6.08 million).

Read More

Sonova Announces Expected ‘Return to Growth’ in Second Half of 2020/21

Sonova now expects sales for the first half of FY 2020/21 to reach around 79% of the prior year level at constant exchange rates and to achieve an adjusted EBITA margin in Swiss francs of approximately 15% for the same period. For the second half of the financial year, the Group expects to return to growth, achieving a revenue increase of 4%-8% and a rise in the adjusted EBITA in the range of 20%-30% compared with the prior year period, both at constant exchange rates.

Read More